Single hormone receptor-positive breast cancer patients experienced poor survival outcomes: a systematic review and meta-analysis.

N WuF FuL ChenY LinP YangChuan Wang

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2019)

Among patients with hormone receptor-positive breast cancer, patients with either ER+PR- tumours or ER-PR+ tumours have a higher risk of recurrence and a shorter survival time than those with ER+PR+ tumours. Patients with both types of breast cancer need additional or better treatments.

Keyphrases

positive breast cancer
end stage renal disease
estrogen receptor
endoplasmic reticulum
breast cancer cells
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
free survival
young adults